Literature DB >> 2177723

Somatostatin receptors on human lymphocytes and leukaemia cells.

K Hiruma1, T Koike, H Nakamura, T Sumida, T Maeda, H Tomioka, S Yoshida, T Fujita.   

Abstract

Receptors for somatostatin were identified on mitogen-activated human peripheral blood lymphocytes (PBL) and human leukaemic cells in 87.5% of lymphoblastic leukaemia and in 12.5% of non-lymphocytic leukaemia, using a somatostatin radiobinding assay. The specific binding of 125I-somatostatin of these cells increased linearly with the cell numbers and was suppressed by non-iodinated somatostatin. We investigated the distribution of fluorescent somatostatin to mitogen-activated PBL by using a fluorescence-activated cell sorter (FACS). Over 95% of the cell populations bound fluorescent somatostatin and no distinct predilection was found among certain lymphocyte subpopulations and somatostatin receptor-positive cells. Scatchard analysis showed a single class (low affinity) of binding site on mitogen-activated PBL and two classes (high and low affinity) of specific binding sites on lymphoblastic leukaemia cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2177723      PMCID: PMC1384866     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts.

Authors:  D G Payan; C A Hess; E J Goetzl
Journal:  Cell Immunol       Date:  1984-04-01       Impact factor: 4.868

2.  Somatostatin desensitization: loss of the ability of somatostatin to inhibit cyclic AMP accumulation and adrenocorticotropin hormone release.

Authors:  T Reisine
Journal:  J Pharmacol Exp Ther       Date:  1984-04       Impact factor: 4.030

3.  A nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells.

Authors:  K H Jakobs; K Aktories; G Schultz
Journal:  Nature       Date:  1983 May 12-18       Impact factor: 49.962

4.  Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon.

Authors:  S J Bhathena; J Louie; G P Schechter; R S Redman; L Wahl; L Recant
Journal:  Diabetes       Date:  1981-02       Impact factor: 9.461

5.  The murine IgA-secreting plasmacytoma MOPC-315 expresses somatostatin receptors.

Authors:  R Scicchitano; P Dazin; J Bienenstock; D G Payan; A M Stanisz
Journal:  J Immunol       Date:  1988-08-01       Impact factor: 5.422

6.  The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes.

Authors:  B D Koch; A Schonbrunn
Journal:  Endocrinology       Date:  1984-05       Impact factor: 4.736

7.  Somatostatin has an antiproliferative effect on concanavalin A-activated rat thymocytes.

Authors:  R N Mascardo; R W Barton; P Sherline
Journal:  Clin Immunol Immunopathol       Date:  1984-10

8.  High density of somatostatin receptors in pituitary tumors from acromegalic patients.

Authors:  J C Reubi; A M Landolt
Journal:  J Clin Endocrinol Metab       Date:  1984-12       Impact factor: 5.958

9.  Regulation of lymphokine (gamma-interferon) production by corticotropin.

Authors:  H M Johnson; B A Torres; E M Smith; L D Dion; J E Blalock
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

10.  Substance P recognition by a subset of human T lymphocytes.

Authors:  D G Payan; D R Brewster; A Missirian-Bastian; E J Goetzl
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

View more
  14 in total

1.  Diagnosis and staging of children's lymphoma using the technetium-labelled somatostatin analogue, 99mTc-depreotide.

Authors:  Witold Cholewinski; Jerzy R Kowalczyk; Bogusław Stefaniak; Jolanta Stefaniak; Ewa Poniatowicz-Frasunek; Anna Tarkowska
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-05       Impact factor: 9.236

2.  Measles virus modulates human T-cell somatostatin receptors and their coupling to adenylyl cyclase.

Authors:  S Krantic; A Enjalbert; C Rabourdin-Combe
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 3.  A rare case of primary skeletal muscle lymphoma: the value of octreotide scintigraphy.

Authors:  C Heuschling; F A Houssiau; F Jamar; H Noel; J P Devogelaer; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

4.  Effects of the somatostatin receptor subtype 4 selective agonist J-2156 on sensory neuropeptide release and inflammatory reactions in rodents.

Authors:  Z Helyes; E Pintér; J Németh; K Sándor; K Elekes; A Szabó; G Pozsgai; D Keszthelyi; L Kereskai; M Engström; S Wurster; J Szolcsányi
Journal:  Br J Pharmacol       Date:  2006-09-04       Impact factor: 8.739

5.  Indium-111 octreotide scintigraphy in patients with bone tumours of the extremities.

Authors:  S Inanir; M Unlü; B Okudan; E Cila; S Atik
Journal:  Eur J Nucl Med       Date:  1996-08

Review 6.  Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma.

Authors:  Einat Even-Sapir; Ora Israel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-18       Impact factor: 9.236

7.  Differential effect of the immunomodulatory hormone somatostatin on replication of human immunodeficiency virus type 1 in CD4+ and CD8+ T lymphocytes.

Authors:  L Mercure; D Phaneuf; M A Wainberg
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

8.  Indium-111 pentetreotide scintigraphy in malignant lymphomas.

Authors:  L Sarda; M Duet; J M Zini; B Berolatti; S Benelhadj; G Tobelem; O Mundler
Journal:  Eur J Nucl Med       Date:  1995-10

9.  The value of octreotide scintigraphy in patients with lung cancer.

Authors:  D J Kwekkeboom; G S Kho; S W Lamberts; J C Reubi; J A Laissue; E P Krenning
Journal:  Eur J Nucl Med       Date:  1994-10

10.  Expression of the somatostatin receptor subtype 4 in intact and inflamed pulmonary tissues.

Authors:  Zoltán Varecza; Krisztián Elekes; Terézia László; Anikó Perkecz; Erika Pintér; Zoltán Sándor; János Szolcsányi; Dániel Keszthelyi; Arpád Szabó; Katalin Sándor; Tamás F Molnár; Zalán Szántó; Judit E Pongrácz; Zsuzsanna Helyes
Journal:  J Histochem Cytochem       Date:  2009-08-17       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.